- Home
- POLA vs PHIO Comparison
POLA vs PHIO Comparison
Compare POLA & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- PHIO
- Stock Information
- Founded
- POLA 1979
- PHIO 2011
- Country
- POLA United States
- PHIO United States
- Employees
- POLA N/A
- PHIO N/A
- Industry
- POLA Industrial Machinery/Components
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- PHIO Health Care
- Exchange
- POLA Nasdaq
- PHIO Nasdaq
- Market Cap
- POLA 11.5M
- PHIO 12.1M
- IPO Year
- POLA 2016
- PHIO N/A
- Fundamental
- Price
- POLA $4.06
- PHIO $2.16
- Analyst Decision
- POLA
- PHIO Strong Buy
- Analyst Count
- POLA 0
- PHIO 3
- Target Price
- POLA N/A
- PHIO $10.67
- AVG Volume (30 Days)
- POLA 844.5K
- PHIO 70.7K
- Earning Date
- POLA 11-13-2025
- PHIO 11-13-2025
- Dividend Yield
- POLA N/A
- PHIO N/A
- EPS Growth
- POLA N/A
- PHIO N/A
- EPS
- POLA N/A
- PHIO N/A
- Revenue
- POLA $11,967,000.00
- PHIO N/A
- Revenue This Year
- POLA N/A
- PHIO N/A
- Revenue Next Year
- POLA N/A
- PHIO N/A
- P/E Ratio
- POLA N/A
- PHIO N/A
- Revenue Growth
- POLA 0.14
- PHIO N/A
- 52 Week Low
- POLA $1.53
- PHIO $0.97
- 52 Week High
- POLA $5.75
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- POLA 53.66
- PHIO 47.27
- Support Level
- POLA $3.38
- PHIO $2.08
- Resistance Level
- POLA $3.99
- PHIO $2.17
- Average True Range (ATR)
- POLA 0.50
- PHIO 0.10
- MACD
- POLA -0.14
- PHIO -0.01
- Stochastic Oscillator
- POLA 30.21
- PHIO 25.64
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.